Our investment strategy is focused on positively impacting healthcare and bending the curve of neurodegenerative disorders, mental health, and obesity. We invest in mission-aligned early-stage companies and deliver robust leadership and support services, positioning our partners for venture-scale returns and global impact.
We believe that we are stronger together, and through the Stead Innovators Network, we create opportunities for mentorships, strategic partnerships between our for-profits and nonprofits, and best-practice training across vital start-up topics and needs.
AccuTitle’s platforms act as a hub for real-estate transactions. Its team is at the forefront of innovating real estate technology and is committed to streamlining the complex real estate transaction process to increase productivity, reduce wire fraud, enhance security and maintain flexibility needed by agents across various business models.
ALZpath’s proprietary pTau217 antibody is used by diagnostic leaders around the world to develop blood tests that detect Alzheimer’s disease pathology quickly, accurately, and at scale. ALZpath-powered blood tests enable early Alzheimer’s disease diagnosis, transforming how the disease is detected, treated, and prevented.
The Amydis team is developing ocular tracers for immediate detection of degenerative and systemic diseases. This pioneering technology can accelerate diagnosis, improve the clinical testing of novel therapeutics, and revolutionize treatment.
Cato Healthcare Supply is a leading healthcare supply chain and procurement solutions company serving healthcare systems nationwide. Its technology, supported by a team of experts, manages health system disruptions, optimizes spending, and delivers the products clinicians need to improve patient outcomes.
Darroch Medical Solutions is creating better knowledge workers through its unique patient monitoring platform. Its mission is to improve patient outcomes by providing healthcare practitioners with more accurate knowledge of their patient’s physiology and reducing the incidence of adverse events through intelligent alerts that proactively identify at-risk patients.
Inseer’s mission is to create a culture of workplace safety using cutting-edge technology. Its AI-powered ergonomics solution enables safety teams to proactively address issues before an injury occurs, protecting workers and boosting productivity.
MedWatch Technologies is building a comprehensive metabolic health platform powered by a proprietary, needle-free glucose sensor. The sensor paired with AI-powered coaching delivers hyper-personalized, adaptive interventions that drive sustained behavior change at scale.
Spinogenix is developing a
new class of regenerative therapeutics to restore memory and motor functions lost in neurodegenerative and psychiatric diseases and is advancing the first synaptic regenerative therapy in Alzheimer’s disease.
Follow news from our portfolio companies on LinkedIn